A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)
Clinical trial NCT02493751 · COMPLETED
Trial details
- NCT number
- NCT02493751
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-26
- Primary completion
- 2018-04-03
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.